BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9649238)

  • 1. Positron emission tomography in urological oncology.
    Hoh CK; Seltzer MA; Franklin J; deKernion JB; Phelps ME; Belldegrun A
    J Urol; 1998 Feb; 159(2):347-56. PubMed ID: 9649238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of FDG-PET in the evaluation of urologic malignancies.
    Bender H; Schomburg A; Albers P; Ruhlmann J; Biersack HJ
    Anticancer Res; 1997; 17(3B):1655-60. PubMed ID: 9179213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for urological tumours.
    Hain SF; Maisey MN
    BJU Int; 2003 Jul; 92(2):159-64. PubMed ID: 12823366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and monitoring of urological tumors using positron emission tomography.
    Hofer C; Kübler H; Hartung R; Breul J; Avril N
    Eur Urol; 2001 Nov; 40(5):481-7. PubMed ID: 11752853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in urologic oncology.
    Shvarts O; Han KR; Seltzer M; Pantuck AJ; Belldegrun AS
    Cancer Control; 2002; 9(4):335-42. PubMed ID: 12228759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron-emission tomography imaging in urological oncology: Current aspects and developments.
    Rauscher I; Eiber M; Weber WA; Gschwend JE; Horn T; Maurer T
    Int J Urol; 2018 Nov; 25(11):912-921. PubMed ID: 30103285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging in urology: a rapidly growing successful collaboration.
    Farolfi A; Koschel S; Murphy DG; Fanti S
    Curr Opin Urol; 2020 Sep; 30(5):623-627. PubMed ID: 32701721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in urologic oncology: positron emission tomography molecular imaging.
    Bouchelouche K; Oehr P
    Curr Opin Oncol; 2008 May; 20(3):321-6. PubMed ID: 18391633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
    Bachor R; Kocher F; Gropengiesser F; Reske SN; Hautmann RE
    Urologe A; 1995 Mar; 34(2):138-42. PubMed ID: 7754585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography in prostate and renal cell carcinoma.
    Mathews D; Oz OK
    Curr Opin Urol; 2002 Sep; 12(5):381-5. PubMed ID: 12172424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography in oncourology].
    Ryzhkova DV; Granov AM; Karelin MI; Kostenikov NA; Shkol'nik MI; Tlostanova MS; Stanzhevskiĭ AA; Arzumanov AA
    Vestn Ross Akad Med Nauk; 2005; (9):26-32. PubMed ID: 16250328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography (PET) in the urooncological evaluation of the small pelvis.
    Machtens S; Serth J; Meyer A; Kleinhorst C; Ommer KJ; Herbst U; Kieruij M; Boerner AR
    World J Urol; 2007 Aug; 25(4):341-9. PubMed ID: 17624533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in urological malignancy.
    Brush JP
    Curr Opin Urol; 2001 Mar; 11(2):175-9. PubMed ID: 11224748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
    [No Abstract]   [Full Text] [Related]  

  • 16. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
    Bouchelouche K; Oehr P
    J Urol; 2008 Jan; 179(1):34-45. PubMed ID: 17997425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
    Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
    J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT.
    Yilmaz M; Celen Z; Sevinc A; Karakok M
    Clin Nucl Med; 2009 Sep; 34(9):598-600. PubMed ID: 19692822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET-imaging in tumors of the reproductive trac.
    Reinhardt MJ; Matthies A; Biersack HJ
    Q J Nucl Med; 2002 Jun; 46(2):105-12. PubMed ID: 12114873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography in uro-oncology.
    Hain SF
    Cancer Imaging; 2005 Jan; 5(1):1-7. PubMed ID: 16154810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.